Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04278963Phase 2/3Suspended
Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
Chinese MedicineCoVID-19
Principalinvestigator
NCT04310865Phase 2/3Suspended
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
Chinese MedicineCOVID-19Severe Pneumonia
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hubei Hospital of Traditional Chinese Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jiang-Rong Huang, M.D.

Yangtze University Health Science Center

Moderately Similar
2 trials

Shared therapeutic areas:

Chinese MedicineCOVID-19Severe Pneumonia

Worked with same sponsors:

China Academy of Chinese Medical SciencesJizhong Energy Fengfeng Group Hospital+5 more
Collaborated on 2 trials
Similarity Score38%

Dong Shang, M.D.

Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Chinese MedicineCOVID-19Severe Pneumonia

Worked with same sponsors:

Jizhong Energy Fengfeng Group HospitalNorth China University of Science and Technology+4 more
Collaborated on 1 trial
Similarity Score34%

Zhong Wang, M.D.

China Academy of Chinese Medical Sciences

Moderately Similar
2 trials

Shared therapeutic areas:

Chinese MedicineCOVID-19Severe Pneumonia

Worked with same sponsors:

Jizhong Energy Fengfeng Group HospitalNorth China University of Science and Technology+4 more
Collaborated on 1 trial
Similarity Score34%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Athena Philis-Tsimikas, MD

Scripps Whittier Diabetes Institute

Related
12 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Mitchell S Cairo, MD

New York Medical College

Related
13 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Shai a Efrati, MD

Asaf-Harofhe MC

Related
13 trials

Shared therapeutic areas:

COVID-19
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04278963Phase 2/3PrincipalInvestigator

Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19

Chinese MedicineCoVID-19
Suspended
NCT04310865Phase 2/3PrincipalInvestigator

Yinhu Qingwen Granula for the Treatment of Severe CoVID-19

Chinese MedicineCOVID-19Severe Pneumonia
Suspended

All 2 trials loaded